Clinical science is a broad discipline that requires investigators from diverse backgrounds spanning from molecular and cell biology, animal science, bio/medical informatics to clinical medicine and epidemiology to work together in a team to address a common question. Such multi-disciplinary collaboration allows linkages to be formed between basic biomedical research programs and the clinical enterprise and fosters a continual feedback of data and discoveries between the bench and bedside.
The Singapore Institute for Clinical Sciences (SICS) is the Agency for Science, Technology and Research's (A*STAR's) key initiative to develop world-class clinical sciences programs. Our mission is to improve the health and economic well-being of Singaporeans by better understanding Asian-relevant diseases and by developing new diagnostics and therapeutics.
SICS' in-house research programs, which are led by clinician scientists, are organized around human diseases and involve close collaboration with other scientists and clinicians in Singapore and overseas. We have 2 main intramural programs - namely Growth, Development and Metabolism (on Type 2 Diabetes, Obesity and neuro-cognition) and Infection and Immunity (on human host response to infection). Our research facilities are housed in the Brenner Centre for Molecular Medicine within the NUS campus. The institute also has extensive extramural outreach programs including yearly grant calls, common interest groups organized in partnership with the Singapore Bioimaging Consortium (Metabolic Interest Group) and the Singapore Immunology Network (Infection and Immunity Seminar Series) as well as a training program in investigational medicine with the Lilly-NUS Centre for Clinical Pharmacology.
